Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thyroid Neoplasms × NVP-BKM120 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 22 Neoplasm Metastasis 15 Glioblastoma 6 Carcinoma, Non-Small-Cell Lung 6 Colorectal Neoplasms 5 Triple Negative Breast Neoplasms 4 Recurrence 4 Ovarian Neoplasms 4 Endometrial Neoplasms 4 Brain Neoplasms 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Neoplasms 3 Lymphoma, Mantle-Cell 3 Lymphoma, Follicular 3 Hereditary Sensory and Autonomic Neuropathies 3 Solid Tumors 2 Melanoma 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Head and Neck Neoplasms 2 Esophageal Neoplasms 2 Waldenstrom Macroglobulinemia 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1

Interventions

Iodine-131 14 lenvatinib 11 Magnetic Resonance Spectroscopy 10 trametinib 9 Thyrotropin Alfa 9 Sorafenib 9 vandetanib 8 pembrolizumab 8 Paclitaxel 8 dabrafenib 7 Thyroxine 7 selpercatinib 6 Surgical Procedures, Operative 6 Sunitinib 6 Everolimus 6 pazopanib 5 cabozantinib 5 Vemurafenib 5 Saline Solution 5 Cyclophosphamide 5 anlotinib 4 Triiodothyronine 4 Thyroidectomy 4 Radiofrequency Ablation 4 Nivolumab 4 Fluorodeoxyglucose F18 4 Docetaxel 4 Dexmedetomidine 4 fosbretabulin 3 durvalumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01830504 2016-10-05

BKM120

Hospices Civils de Lyon

Phase 2 Unknown

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡